Literature DB >> 20363162

Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview.

Emil Scosyrev1, James Messing, Katia Noyes, Peter Veazie, Edward Messing.   

Abstract

The Surveillance, Epidemiology, and End Results (SEER) program is a commonly used data source in cancer research. This article provides an introduction to the SEER database, describes important data items available from SEER on the most commonly diagnosed urologic malignancies (prostate, bladder, and kidney cancers), and reviews limitations of SEER data for urologic oncology research. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20363162     DOI： 10.1016/j.urolonc.2009.11.005

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


  30 in total

1.  Prevalence of Small Intestine Carcinoid Tumors: A US Population-Based Study 2012-2017.

Authors:  Mohannad Abou Saleh; Emad Mansoor; Mohammad Anindo; Gerard Isenberg
Journal:  Dig Dis Sci       Date:  2018-12-05       Impact factor: 3.199

2.  Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.

Authors:  Jennifer M Taylor; Andrew Feifer; Caroline J Savage; Alexandra C Maschino; Melanie Bernstein; Harry W Herr; S Machele Donat
Journal:  BJU Int       Date:  2011-07-01       Impact factor: 5.588

3.  Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.

Authors:  Elizabeth J Davis; Jennifer L Beebe-Dimmer; Cecilia L Yee; Kathleen A Cooney
Journal:  Cancer       Date:  2014-05-19       Impact factor: 6.860

4.  Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

Authors:  Benjamin M Johnson; Bently P Doonan; Faisal F Radwan; Azizul Haque
Journal:  Open Prost Cancer J       Date:  2010-01-01

5.  Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data.

Authors:  Marc C Smaldone; Brian Egleston; John M Hollingsworth; Brent K Hollenbeck; David C Miller; Todd M Morgan; Simon P Kim; Aseem Malhotra; Elizabeth Handorf; Yu-Ning Wong; Robert G Uzzo; Alexander Kutikov
Journal:  Med Care       Date:  2017-04       Impact factor: 2.983

6.  Comparison of surgical, oncological, and functional outcomes of robot-assisted and laparoscopic radical prostatectomy in patients with prostate cancer.

Authors:  Abdurrahman İnkaya; Ahmet Tahra; Resul Sobay; Ali Kumcu; Eyüp Veli Küçük; Uğur Boylu
Journal:  Turk J Urol       Date:  2019-11-01

Review 7.  The opportunities and shortcomings of using big data and national databases for sarcoma research.

Authors:  Heather G Lyu; Adil H Haider; Adam B Landman; Chandrajit P Raut
Journal:  Cancer       Date:  2019-05-15       Impact factor: 6.860

8.  Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells.

Authors:  Benjamin M Johnson; Faisal F Y Radwan; Azim Hossain; Bently P Doonan; Jessica D Hathaway-Schrader; Jason M God; Christina V Voelkel-Johnson; Narendra L Banik; Sakamuri V Reddy; Azizul Haque
Journal:  J Cell Biochem       Date:  2018-10-30       Impact factor: 4.429

9.  Randomized trial of print messaging: the role of the partner and monitoring style in promoting provider discussions about prostate cancer screening among African American men.

Authors:  Suzanne M Miller; Pagona Roussi; John Scarpato; Kuang-Yi Wen; Fang Zhu; Gem Roy
Journal:  Psychooncology       Date:  2013-10-15       Impact factor: 3.894

10.  Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.

Authors:  Mark Steven Miller; Peter Allen; Teresa A Brentnall; Michael Goggins; Ralph H Hruban; Gloria M Petersen; Chinthalapally V Rao; David C Whitcomb; Randall E Brand; Suresh T Chari; Alison P Klein; David M Lubman; Andrew D Rhim; Diane M Simeone; Brian M Wolpin; Asad Umar; Sudhir Srivastava; Vernon E Steele; Jo Ann S Rinaudo
Journal:  Pancreas       Date:  2016-09       Impact factor: 3.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.